Company Data
DiaMedica Therapeutics Inc.
Ticker
DMAC
Current Price
$8.2 -1.56%
Market Cap
$442.2M
Price Target
Refer to Report
Volume
185.6K
52wk Range
$5.245 - $10.4195
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.